You may also like
The GP IIb/IIIa Inhibitor Abciximab (ReoPro((R))) Decreases Activation and Interaction of Platelets and Leukocytes During In Vitro Cardiopulmonary Bypass Simulation
The aim of this study was to investigate the effect of the GP IIb/IIIa inhibitor abciximab (ReoPro((R))) on the function and interaction of platelets and leukocytes during experimental CPB.
1 min read
Heparin-coated vs. Non-coated Cardiopulmonary Bypass Circuits: Comparing Immediate Results with Different Target Activated Clotting Time
Heparin-coated circuits and reduced level of systemic heparinization with 300 seconds of target ACT level in cardiac surgery under CPB are safe and result in a very satisfactory clinical course.
1 min read